Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

Tips for Staying Sane While Dealing With Insurance

November 14th 2017, 12:11am

Article

People with cancer have to gear up for the emotional and mental workout of dealing with insurance. Here are some tips for coping.

Survey Asks Why Some Ovarian Cancer Patients Choose Maintenance Therapy

November 11th 2017, 12:18am

Article

Many patients who completed the survey felt maintenance therapy would help them buy time.

New Options Are Being Explored in Ovarian Cancer

November 6th 2017, 9:14pm

Article

An antibody–drug conjugate is being tested in patients with platinum-resistant ovarian cancer.

Approval Sought for Avastin in the Frontline Ovarian Cancer Setting

October 30th 2017, 5:32pm

Article

If approved, the new indication would make frontline Avastin available in combination with carboplatin and paclitaxel, followed by Avastin alone, for women with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer. The FDA is expected to render a decision on the sBLA by June 25, 2018.

A Squirrel Named Mary Jane

October 27th 2017, 6:52am

Article

Did a miracle occur after Mary Jane passed away from ovarian cancer?

Judge Tosses $417 Million Award in Ovarian Cancer Lawsuit Against Johnson & Johnson

October 23rd 2017, 7:33pm

Article

The largest ruling yet was overturned by a California judge on Oct. 20.

Can Treatment at a Large Cancer Center Mitigate Racial Disparities in Ovarian Cancer?

October 12th 2017, 8:44pm

Article

Studies have shown that African American women tend to have worse outcomes after ovarian cancer surgery than their white counterparts.

New Maintenance Therapy for Ovarian Cancer Seeks FDA Approval

October 12th 2017, 5:53pm

Article

The pharmaceutical company Clovis Oncology filed a supplemental new drug application (sNDA) to the FDA for their drug Rubraca (rucaparib) to be used as maintenance therapy for patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy.

Expert Discusses Exciting Advances in Ovarian Cancer

October 6th 2017, 1:02am

Video

Rebecca Arend, M.D., gynecologic oncologist at University of Alabama at Birmingham Hospital, discusses the rapidly changing field of ovarian cancer.

Better Understanding of Ovarian Cancer Is Needed, Expert Says

October 4th 2017, 6:11pm

Article

To better understand ovarian cancer, as well as predict when women might relapse, it is crucial that researchers start investigating more of the molecular phases of the disease, says Peter Dottino, M.D.